Cargando…

Analysis of Oncogenes and Tumor Suppressor Genes in Human Breast Cancer

Oncogenes (c‐erbB‐2, c‐myc, and some genes linked to the 11q13 lesion), tumor suppressor genes (retinoblastoma gene, p53) and an antimetastatic gene (nm23/nucleoside diphosphate kinase) play important roles in breast cancer progression. Amplification of c‐erbB‐2, c‐myc, and int‐2, and expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamashita, Hiroko, Kobayashi, Shunzo, Iwase, Hirotaka, Itoh, Yukashi, Kuzushima, Tatsuya, Iwata, Hiroji, Itoh, Kazuko, Naito, Akihiro, Yamashita, Toshinari, Masaoka, Akira, Kimura, Narimichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1993
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919268/ https://www.ncbi.nlm.nih.gov/pubmed/8104920 http://dx.doi.org/10.1111/j.1349-7006.1993.tb02060.x

Ejemplares similares

Estrogen Receptor, c‐erbB‐2 and nm23/NDP Kinase Expression in the Intraductal and Invasive Components of Human Breast Cancers
por: Kobayashi, Shunzo, et al.
Publicado: (1992)

Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast Carcinomas
por: Iwata, Hiroji, et al.
Publicado: (1996)

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer
por: Yamashita, Hiroko, et al.
Publicado: (2004)

p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer
por: Yamashita, Hiroko, et al.
Publicado: (2006)

Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast
por: Zhang, Zhenhuan, et al.
Publicado: (2003)

Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients
por: Toyama, Tatsuya, et al.
Publicado: (2007)

Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer
por: Yamashita, Hiroko, et al.
Publicado: (2005)

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2013)

Reproductive history and breast cancer risk
por: Kobayashi, Shunzo, et al.
Publicado: (2012)

GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development
por: Kuwahara, Kazuhiko, et al.
Publicado: (2016)

Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study
por: Kotani, Haruru, et al.
Publicado: (2022)

Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer
por: Kai, Kazuharu, et al.
Publicado: (2008)

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers
por: Toyama, Tatsuya, et al.
Publicado: (2008)

Tumor-Suppressor Genes and Oncogenes
Publicado: (1993)

Oncogenes and tumor-suppressor genes.
por: Lehman, T A, et al.
Publicado: (1991)

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
por: Okumura, Yasuhiro, et al.
Publicado: (2008)

RUNX family: Oncogenes or tumor suppressors
por: Otálora-Otálora, Beatriz Andrea, et al.
Publicado: (2019)

Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre- and postmenopausal Japanese women
por: Guo, Jiazhi, et al.
Publicado: (2017)

Electroretinography recordings using a light emitting diode active corneal electrode in healthy beagle dogs
por: Itoh, Yoshiki, et al.
Publicado: (2013)

A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer
por: Shiba, Eiichi, et al.
Publicado: (2015)

Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial
por: Ohashi, Yasuo, et al.
Publicado: (2017)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

Tyrosol ameliorates lipopolysaccharide-induced ocular inflammation in rats via inhibition of nuclear factor (NF)-κB activation
por: SATO, Kazuaki, et al.
Publicado: (2016)

Relative potency of tyrosol in the treatment of endotoxin-induced uveitis in rats
por: SATO, Kazuaki, et al.
Publicado: (2016)

Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3
por: Yahara, Yasuhito, et al.
Publicado: (2016)

Corrigendum: Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3
por: Yahara, Yasuhito, et al.
Publicado: (2016)

Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017)

SIRT3: Oncogene and Tumor Suppressor in Cancer
por: Torrens-Mas, Margalida, et al.
Publicado: (2017)

Plastic-scale-model assembly of ultrathin film MEMS piezoresistive strain sensor with conventional vacuum-suction chip mounter
por: Takamatsu, Seiichi, et al.
Publicado: (2019)

Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)

Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles
por: Naito, M, et al.
Publicado: (2007)

Ratio of Expression of p16(INK4a) to p14(ARF) Correlates with the Progression of Non‐small Cell Lung Cancer
por: Moriyama, Satoru, et al.
Publicado: (2002)

Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.
por: Lechner, J F, et al.
Publicado: (1997)

Genetic Basis for Carcinogenesis. Tumor Suppressor Genes and Oncogenes
por: Rabbitts, P.
Publicado: (1992)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?
por: Pickard, Adam, et al.
Publicado: (2015)

RhoB: Team Oncogene or Team Tumor Suppressor?
por: Ju, Julia A., et al.
Publicado: (2018)

Identification and analysis of mutational hotspots in oncogenes and tumour suppressors
por: Baeissa, Hanadi, et al.
Publicado: (2017)

Tumor Suppressors Having Oncogenic Functions: The Double Agents
por: Datta, Neerajana, et al.
Publicado: (2020)

Somatic selection distinguishes oncogenes and tumor suppressor genes
por: Chandrashekar, Pramod, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_niok3mjqsrbc6uog9oaner5dud